Grifols | GRFS - Aktuelle Verpflichtungen

Aktienkurs
7.65
Täglich Wechseln
0.07 0.92%
Monatlich
-15.66%
Jährlich
-1.80%
Q1 Prognose
7.36




Aktuelle Verpflichtungen Veränderung Datum
Alaunos Therapeutics USD 921K 153K 2025-09
Arca Biopharma USD 15.37M 5.59M 2025-12
aTyr Pharma USD 113.19M 97.51M 2025-12
Bio Path USD 8.68M 819K 2025-09
Brainstorm Cell Therapeutics USD 9.02M 495K 2025-09
Capricor Therapeutics USD 35.84M 7.69M 2025-12
Cara Therapeutics USD 10.68M 9.48M 2025-06
Esperion Therapeutics USD 300.81M 58.22M 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
Grifols EUR 2.37B 156.97M 2025-12
Immunic USD 30.08M 2.77M 2025-09
Infinity Pharmaceuticals USD 12.06M 775K 2023-06
Minerva Neurosciences USD 2.29M 381K 2025-12
Nektar Therapeutics USD 66.34M 5.05M 2025-09
Sangamo BioSciences USD 47.66M 1.9M 2025-06
TherapeuticsMD USD 5.82M 655K 2024-06